<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02334059</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001623</org_study_id>
    <nct_id>NCT02334059</nct_id>
  </id_info>
  <brief_title>Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery</brief_title>
  <official_title>Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid sparing analgesia is extremely important in the post-operative obese population. With
      more and more obese patients entering the operating room a multi-modal approach to analgesia
      is crucial. Finding effective alternatives to opioid therapy is the rationale of this
      proposal. Literature involving ketamine and magnesium in bariatric surgical patients is very
      sparse.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patient will be identified by surgeon and consented by member of the research team

        2. Patient will be randomized to one of three groups on the day of surgery

        3. Following securement of the endotracheal tube, the study medication will be administered
           over 10 minutes via an IV infusion pump.

        4. The subject will receive ketamine, ketamine plus magnesium or a placebo.

        5. Following surgery, the patient will be taken to the post anesthesia care unit (PACU) and
           set up with standard ASA monitoring as well as end-tidal CO2 via nasal cannula. A
           hydromorphone patient controlled analgesia (PCA) pump will be set-up by nursing and
           given to the patient. Standard dosing of 0.2 mg bolus, every 6 minutes with a maximum 2
           mg will be the starting dose as is standard for these patients post-operatively.

        6. Primary outcome will be the total amount of hydromorphone used in the first 24 hours
           post-operatively.

           .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">March 13, 2019</completion_date>
  <primary_completion_date type="Actual">March 13, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Hydromorphone Use</measure>
    <time_frame>During surgery and 24 hours post-op</time_frame>
    <description>Total hydromorphone use in 1st 24 hours post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores Using Verbal Analogue Scale (VAS)</measure>
    <time_frame>Preoperatively and the 1st 24 hours post-op</time_frame>
    <description>Pain scores using VAS scale will be recorded pre-operatively, in the PACU, and every 4 hours until 24 hours post-op. The VAS is a 10 point scale, where 0 = no pain and 10 = the worst pain a subject has ever felt. The highest value 10, indicates an extreme self reported level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Minimum Alveolar Concentration (MAC) of Desflurane</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>The average MAC concentration of desflurane will be recorded during the intraoperative period. The Minimum Alveolar Concentration (MAC) of an inhaled anesthetic is the alveolar (or end-expiratory) concentration at which 50% of patients will not show a motor response to a standardized surgical incision.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine: 0.5 mg/kg IV dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine plus magnesium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (normal saline)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Ketamine infusion plus placebo infusion of normal saline</description>
    <arm_group_label>Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine plus magnesium</intervention_name>
    <description>Ketamine plus magnesium infusion</description>
    <arm_group_label>Ketamine plus magnesium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 placebo infusions</description>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects undergoing laparoscopic sleeve gastrectomy

          2. Consenting adults age 18-80

          3. ASA II to ASA III

          4. Ability to understand and use a PCA

          5. Required to be hospitalized for at least 24 hours post-op

        Exclusion Criteria:

          1. Patient refusal

          2. Chronic opiate use (daily opiate use for &gt;3 months)

          3. Chronic Kidney disease (Creatinine&gt;2)

          4. Known allergy or adverse effect of ketamine, magnesium or hydromorphone

          5. Patients with documented psychiatry (Maniac or MDP) history

          6. Patient unable to give informed consent

          7. Patient with limited or no English fluency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjib Adhikary, MB, BS,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PSHMC College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Milton S.Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 23, 2014</study_first_submitted>
  <study_first_submitted_qc>January 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2015</study_first_posted>
  <results_first_submitted>July 15, 2019</results_first_submitted>
  <results_first_submitted_qc>November 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 19, 2019</results_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Sanjib D Adhikary</investigator_full_name>
    <investigator_title>Associate professor, Department of Anesthesiology,</investigator_title>
  </responsible_party>
  <keyword>opioid sparing</keyword>
  <keyword>ketamine</keyword>
  <keyword>obese</keyword>
  <keyword>magnesium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT02334059/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ketamine</title>
          <description>Ketamine: 0.5 mg/kg IV dose
Ketamine: Ketamine infusion plus placebo infusion of normal saline
Placebo: 2 placebo infusions</description>
        </group>
        <group group_id="P2">
          <title>Ketamine Plus Magnesium</title>
          <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV
Ketamine plus magnesium: Ketamine plus magnesium infusion</description>
        </group>
        <group group_id="P3">
          <title>Placebo</title>
          <description>Placebo (normal saline)
Placebo: 2 placebo infusions</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ketamine</title>
          <description>Ketamine: 0.5 mg/kg IV dose
Ketamine: Ketamine infusion plus placebo infusion of normal saline
Placebo: 2 placebo infusions</description>
        </group>
        <group group_id="B2">
          <title>Ketamine Plus Magnesium</title>
          <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV
Ketamine plus magnesium: Ketamine plus magnesium infusion</description>
        </group>
        <group group_id="B3">
          <title>Placebo</title>
          <description>Placebo (normal saline)
Placebo: 2 placebo infusions</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="37"/>
            <count group_id="B4" value="108"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.68" spread="10.82"/>
                    <measurement group_id="B2" value="44.15" spread="11.91"/>
                    <measurement group_id="B3" value="39.97" spread="11.60"/>
                    <measurement group_id="B4" value="42.56" spread="11.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.48" spread="9.85"/>
                    <measurement group_id="B2" value="45.57" spread="6.73"/>
                    <measurement group_id="B3" value="47.37" spread="8.70"/>
                    <measurement group_id="B4" value="46.84" spread="8.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of Surgery</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.14" spread="8.25"/>
                    <measurement group_id="B2" value="67.06" spread="15.12"/>
                    <measurement group_id="B3" value="64.78" spread="13.23"/>
                    <measurement group_id="B4" value="62.19" spread="13.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-operative Pain Score</title>
          <description>Pain Scores will be determined pre-operatively using the Visual Analogue Scale (VAS). The VAS is a 10 point scale, where 0 = no pain and 10 = worst pain a subject has ever felt.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.27" spread="1.04"/>
                    <measurement group_id="B2" value="0.35" spread="0.95"/>
                    <measurement group_id="B3" value="0.41" spread="1.3"/>
                    <measurement group_id="B4" value="0.34" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-operative sedation score</title>
          <description>Sedation scoring will be determined using the Modified Ramsay Sedation Scale. The Modified Ramsay Sedation Scale is a 6 point scale used to determine alertness, where 1 = patient is awake, anxious, agitated, or restless and 6 = patient with no response to any stimuli (light, noise, or pain). A higher number represents an increased sedative state.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" spread="0.0"/>
                    <measurement group_id="B2" value="1.97" spread="0.17"/>
                    <measurement group_id="B3" value="2" spread="0.16"/>
                    <measurement group_id="B4" value="2" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-operative PONV score</title>
          <description>The Pre-Operative PONV score will be determined using the PONV Impact Scale. This scale consists of two questions (rated from 0 to 3) for both questions and the sum of the responses are added for a total PONV score.
Question 1 asks if an individual has vomited or had any dry retching, where 0 = Not at all, 1 = Once, 2= Twice, and 3= Three or more times.
Question 2 asks if an individual has experienced a feeling of nausea, where 0 = Not at all, 1 = Sometimes, 2 = Often or most of the time, and 3 = All of the time.
total score (mean and std deviation) is reported and total ranges from 0-3.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="37"/>
                    <count group_id="B4" value="108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.16" spread="0.50"/>
                    <measurement group_id="B2" value="0.03" spread="0.17"/>
                    <measurement group_id="B3" value="0.14" spread="0.54"/>
                    <measurement group_id="B4" value="0.11" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Hydromorphone Use</title>
        <description>Total hydromorphone use in 1st 24 hours post-operatively.</description>
        <time_frame>During surgery and 24 hours post-op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Ketamine: 0.5 mg/kg IV dose
Ketamine: Ketamine infusion plus placebo infusion of normal saline
Placebo: 2 placebo infusions</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Plus Magnesium</title>
            <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV
Ketamine plus magnesium: Ketamine plus magnesium infusion</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo (normal saline)
Placebo: 2 placebo infusions</description>
          </group>
        </group_list>
        <measure>
          <title>Total Hydromorphone Use</title>
          <description>Total hydromorphone use in 1st 24 hours post-operatively.</description>
          <units>mcg/Kg</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="161.5" lower_limit="119.6" upper_limit="203.3"/>
                    <measurement group_id="O2" value="159.6" lower_limit="109.4" upper_limit="209.7"/>
                    <measurement group_id="O3" value="195.9" lower_limit="149.6" upper_limit="242.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.9" lower_limit="20.5" upper_limit="63.3"/>
                    <measurement group_id="O2" value="47.8" lower_limit="24.6" upper_limit="71.0"/>
                    <measurement group_id="O3" value="47.3" lower_limit="24.1" upper_limit="70.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Scores Using Verbal Analogue Scale (VAS)</title>
        <description>Pain scores using VAS scale will be recorded pre-operatively, in the PACU, and every 4 hours until 24 hours post-op. The VAS is a 10 point scale, where 0 = no pain and 10 = the worst pain a subject has ever felt. The highest value 10, indicates an extreme self reported level of pain.</description>
        <time_frame>Preoperatively and the 1st 24 hours post-op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Ketamine: 0.5 mg/kg IV dose
Ketamine: Ketamine infusion plus placebo infusion of normal saline
Placebo: 2 placebo infusions</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Plus Magnesium</title>
            <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV
Ketamine plus magnesium: Ketamine plus magnesium infusion</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo (normal saline)
Placebo: 2 placebo infusions</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores Using Verbal Analogue Scale (VAS)</title>
          <description>Pain scores using VAS scale will be recorded pre-operatively, in the PACU, and every 4 hours until 24 hours post-op. The VAS is a 10 point scale, where 0 = no pain and 10 = the worst pain a subject has ever felt. The highest value 10, indicates an extreme self reported level of pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prior to Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" lower_limit="-0.03" upper_limit="0.84"/>
                    <measurement group_id="O2" value="0.35" lower_limit="0.02" upper_limit="0.68"/>
                    <measurement group_id="O3" value="0.27" lower_limit="-0.08" upper_limit="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.78" lower_limit="4.86" upper_limit="6.71"/>
                    <measurement group_id="O2" value="6.03" lower_limit="4.86" upper_limit="6.78"/>
                    <measurement group_id="O3" value="5.95" lower_limit="4.91" upper_limit="6.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.89" lower_limit="3.20" upper_limit="4.57"/>
                    <measurement group_id="O2" value="4.29" lower_limit="3.53" upper_limit="5.06"/>
                    <measurement group_id="O3" value="4.65" lower_limit="4.01" upper_limit="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8h after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" lower_limit="3.09" upper_limit="4.24"/>
                    <measurement group_id="O2" value="3.75" lower_limit="2.9" upper_limit="4.60"/>
                    <measurement group_id="O3" value="3.64" lower_limit="3.08" upper_limit="4.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12h after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.16" lower_limit="2.59" upper_limit="3.73"/>
                    <measurement group_id="O2" value="3.91" lower_limit="3.28" upper_limit="4.53"/>
                    <measurement group_id="O3" value="2.69" lower_limit="2.07" upper_limit="3.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16h after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.97" lower_limit="2.3" upper_limit="3.64"/>
                    <measurement group_id="O2" value="3.64" lower_limit="2.89" upper_limit="4.38"/>
                    <measurement group_id="O3" value="3.09" lower_limit="2.51" upper_limit="3.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20h after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.22" lower_limit="2.42" upper_limit="4.01"/>
                    <measurement group_id="O2" value="4.13" lower_limit="3.45" upper_limit="4.8"/>
                    <measurement group_id="O3" value="2.94" lower_limit="2.36" upper_limit="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24h after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.24" lower_limit="2.59" upper_limit="3.88"/>
                    <measurement group_id="O2" value="3.48" lower_limit="2.81" upper_limit="4.15"/>
                    <measurement group_id="O3" value="3.33" lower_limit="2.63" upper_limit="4.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraoperative Minimum Alveolar Concentration (MAC) of Desflurane</title>
        <description>The average MAC concentration of desflurane will be recorded during the intraoperative period. The Minimum Alveolar Concentration (MAC) of an inhaled anesthetic is the alveolar (or end-expiratory) concentration at which 50% of patients will not show a motor response to a standardized surgical incision.</description>
        <time_frame>Intraoperative period</time_frame>
        <population>Intraoperative period: Intraoperative Minimum Alveolar Concentration (MAC) of desflurane</population>
        <group_list>
          <group group_id="O1">
            <title>Ketamine</title>
            <description>Ketamine: 0.5 mg/kg IV dose
Ketamine: Ketamine infusion plus placebo infusion of normal saline
Placebo: 2 placebo infusions</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Plus Magnesium</title>
            <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV
Ketamine plus magnesium: Ketamine plus magnesium infusion</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo (normal saline)
Placebo: 2 placebo infusions</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Minimum Alveolar Concentration (MAC) of Desflurane</title>
          <description>The average MAC concentration of desflurane will be recorded during the intraoperative period. The Minimum Alveolar Concentration (MAC) of an inhaled anesthetic is the alveolar (or end-expiratory) concentration at which 50% of patients will not show a motor response to a standardized surgical incision.</description>
          <population>Intraoperative period: Intraoperative Minimum Alveolar Concentration (MAC) of desflurane</population>
          <units>Minimal Alveolar Concentration (MAC)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.05" lower_limit="3.74" upper_limit="4.35"/>
                    <measurement group_id="O2" value="4.02" lower_limit="3.73" upper_limit="4.32"/>
                    <measurement group_id="O3" value="4.34" lower_limit="3.98" upper_limit="4.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Perioperative time period (within 24 hours) up to 24 hours post surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Ketamine</title>
          <description>Ketamine: 0.5 mg/kg IV dose
Ketamine: Ketamine infusion plus placebo infusion of normal saline
Placebo: 2 placebo infusions</description>
        </group>
        <group group_id="E2">
          <title>Ketamine Plus Magnesium</title>
          <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV
Ketamine plus magnesium: Ketamine plus magnesium infusion</description>
        </group>
        <group group_id="E3">
          <title>Placebo</title>
          <description>Placebo (normal saline)
Placebo: 2 placebo infusions</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="37"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sanjib D Adhikary</name_or_title>
      <organization>Penn State Health Anesthesiology and Perioperative Medicine</organization>
      <phone>717-531-6597</phone>
      <email>sadhikary1@pennstatehealth.psu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

